Page results
-
A patient with motor neurone disease was able to control a computer just by using his thoughts following the UK’s first Neuralink implant surgery at UCLH’s National Hospital for Neurology and Neurosurgery (NHNN) in October 2025.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 28 January 2026.
-
UCLH Charity is delighted to announce a generous £1.5 million donation from the Bukhman Philanthropies.
-
A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.
-
A UCLH clinician scientist has won a prestigious international award for his groundbreaking work on how tumours evolve, which is helping to explain why cancer treatments sometimes fail and paving the way for more precise, personalised therapies.
-
This page is designed to help parents/carers understand the process and what to expect during their child’s admission to the Paediatric ward.
-
The artist Caroline Walker, whose work was featured in The Guardian at the weekend, created some of the paintings being shown in her current solo exhibition, during an artist residency at UCLH in 2021.
-
To enable us to provide a quick response when you need it most, we have developed these Frequently Asked Questions (FAQs). We kindly ask you to read through these before contacting our team as you may find the answer to your question here.
-
The UCLH Macmillan Support and Information Service Coffee Morning — a welcoming space for anyone affected by cancer or blood conditions to connect, share experiences, and find support.
File results
-
FOI/2022/0147 - Oesophageal and gastric cancer drug treatments
-
FOI/2022/0148 - Maternity related overseas services
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0151 - Omnipod patch pump
-
FOI/2022/0153 - Central water treatment equipment for renal dialysis
-
FOI/2022/0154 - Immunoglobulin treatments (for any disease)
-
FOI/2022/0155 - Patient hospital bedside and electronic patient notes
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0167 - Prostate cancer drug treatments
-
FOI/2022/0168 - Geographic locations of patients